Kim DH, Sun D, Storck WK, Welker Leng KR, et al. BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program. Clin Cancer Res 2021 Jun 18. pii: 1078-0432.CCR-20-4968.
PMID: 34145028